Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2015 Sep 1.
Published in final edited form as: Mov Disord. 2014 Jul 7;29(10):1329–1330. doi: 10.1002/mds.25965

Purkinje Cell Loss in Essential Tremor

Elan D Louis 1,2,3,4, Phyllis L Faust 5
PMCID: PMC4162819  NIHMSID: NIHMS608449  PMID: 25042039

The recent study published by Symanski et al.1 reports similar Purkinje cell counts in a group of “essential tremor” cases compared to a group of controls. There are a number of major methodological problems with the design of the study and these problems cast doubt on the validity of the results that are reported.

The first problem is that of case definition. ET was defined simply as “action tremor of the hand, voice, or isolated head tremor.” This loose definition does little to exclude enhanced physiological tremor, which is an action tremor of the hands, and is very common in the elderly. While the authors note that tremor had to have a rating of 2 or higher, for their cases who had had tremor for 3 or more years (i.e., the vast majority of their cases), a low amplitude tremor was deemed acceptable. Indeed, there is no specified lower limit of tremor severity for the bulk of their “ET” cases. This is very problematic and, as a methodological flaw, could by itself account for their null finding. In some of the allied studies from this cohort, these authors are reporting extremely high prevalence values for “ET”, furthering these concerns that there is a problem with their case definition.

The second issue is that the disease duration was very short and this too could account for their results. They try to dismiss this point, writing that there was no association between duration and Purkinje cell linear density. The problem with their argument is that there were so few cases with longer duration, and the range of durations was so narrow, that it would be mathematically challenging, with a correlation coefficient, to detect an association. So, their argument is not valid.

In discussing the results of the Canadian group, they correctly note the small sample size, but do not pay heed to the issue of Type II statistical error, which is a real problem with those results.2

In many places, they overstep their results. For example, they write: “it seems clear that ET is unlikely a primary Purkinje cell degeneration”. This study does not show that. It merely demonstrates that, using a sample of elderly people with loosely defined tremor of short duration, they were unable to replicate another group’s results.

They indicate that our group has not adjusted for alcohol intake or anticonvulsant use, but this is not the case in more recent papers.3, 4 A more thorough reading of those papers is called for.

Their statement that Purkinje cell loss should be present even before the development of tremor is not a sophisticated argument. For example, if Purkinje cell loss were a by-product of longstanding pathological molecular/cellular processes occurring in ET, it might not be the earliest finding. Rather, it could be a relatively late finding and might long-follow the onset of tremor. More recent papers emphasize an array of pathological findings involving Purkinje and neighboring cells in ET, and portray Purkinje cell loss in ET as a relatively late event.4, 5

Acknowledgements

None.

Full Financial Disclosure for the Previous 12 Months:

Elan D. Louis has received research support from the National Institutes of Health: NINDS #R01 NS042859 (principal investigator), NINDS #R01 NS39422 (principal investigator), NINDS #T32 NS07153-24 (principal investigator), NINDS #R01 NS073872 (co-principal investigator), NINDS #R21 NS077094 (co-Investigator), and NINDS #R01 NS36630 (co-Investigator), as well as the Parkinson's Disease Foundation (principal investigator), the Arlene Bronstein Essential Tremor Research Fund (Columbia University), and the Claire O'Neil Essential Tremor Research Fund (Columbia University). Phyllis L. Faust has received research support from the National Institutes of Health: NINDS #R01 NS042859 (co-Investigator), NINDS #R21 NS077094 (Principle Investigator).

Footnotes

Conflict of Interest Statement: The authors declare that there are no conflicts of interest and no competing financial interests.

Ethics approval: Not applicable.

Contributions of Each Author:

Elan D. Louis: conception and design, initial draft and critical revision of manuscript for important intellectual content.

Phyllis L Faust: conception and design, initial draft and critical revision of manuscript for important intellectual content.

References

  • 1.Symanski C, Shill HA, Dugger B, et al. Essential tremor is not associated with cerebellar Purkinje cell loss. Mov Disord. 2014 Feb 15; doi: 10.1002/mds.25845. [Epub ahead of print]. [DOI] [PubMed] [Google Scholar]
  • 2.Louis ED, Faust PL, Vonsattel JP. Purkinje cell loss is a characteristic of essential tremor: Towards a more mature understanding of pathogenesis. Parkinsonism Relat Disord. 2012;18:1003–1004. doi: 10.1016/j.parkreldis.2012.06.017. [DOI] [PubMed] [Google Scholar]
  • 3.Babij R, Lee M, Cortes E, Vonsattel JP, Faust PL, Louis ED. Purkinje cell axonal anatomy: quantifying morphometric changes in essential tremor versus control brains. Brain. 2013;136:3051–3061. doi: 10.1093/brain/awt238. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Louis ED, Kuo SH, Vonsattel JP, Faust PL. Torpedo formation and Purkinje cell loss: Modeling their relationship in cerebellar disease. Cerebellum. 2014 Mar 5; doi: 10.1007/s12311-014-0556-5. [Epub ahead of print]. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Louis ED. From Neurons to neuron neighborhoods: the Rewiring of the cerebellar cortex in essential tremor. Cerebellum. 2014 Jan 17; doi: 10.1007/s12311-013-0545-0. [Epub ahead of print]. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES